Texas Archival Resources Online

TABLE OF CONTENTS


Descriptive Summary

Scope and Content Note

Organization of Collection

Restrictions

Index Terms

Administrative Information

Description of Series

Grants

University administration

Article drafts and correspondence

Professional associations

Laboratory notes 1982-1988

Conferences

Return to Part 1 of the George Perry papers

University of Texas San Antonio

Inventory of the George Perry Papers, 1973-2010



Descriptive Summary

Creator:Perry, George, 1953-.
Title: George Perry Papers
Dates:1973-2010
Creator Abstract:George Perry is a neuroscientist and Dean of the College of Sciences and Professor of Biology at the University of Texas at San Antonio and a leading researcher in the field of Alzheimer's disease.
Content Abstract:The George Perry Papers include correspondence, email, grant files, committee files, drafts, laboratory notes, conference files, and slides that document his academic career and research activities primarily related to the cytopathology of Alzheimer's disease.
Identification:UA 99.0020
Extent:52 linear feet (52 boxes) + 38, 839 electronic files (6.21 GB)
Language:Materials are in English.
Repository:University of Texas at San Antonio Libraries Special Collections

Biographical Note

George Perry is a neuroscientist and Dean of the College of Sciences and Professor of Biology at the University of Texas at San Antonio and a leading researcher in the field of Alzheimer's disease. Born April 12, 1953 in Lompoc, California, Perry received his bachelor's of arts degree in Zoology from University of California, Santa Barbara in 1974 and his PhD in Marine Biology from Scripps Institution of Oceanography of University of California at San Diego in 1979. He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of Dr. Bill Brinkley, Joseph Bryan and Anthony R. Means at Baylor College of Medicine, where his research focused on cytoskeletal abnormalities. In 1995, Perry joined the faculty of Case Western Reserve University, where he eventually became Professor of Pathology in the School of Medicine and where he currently holds an adjunct appointment. Since 2005, he has been the Dean of the College of Sciences and Professor of Biology at the University of Texas at San Antonio.

Perry's research focuses on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. His research explores how oxidative damage plays a role in the initial cytopathological abnormality in Alzheimer disease and the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. His research also looks at the metabolic basis for mitochondrial damage restricted to vulnerable neurons, and the consequences of RNA oxidation on protein synthesis rate and fidelity.

With over 900 publications, Perry is listed as one of the top 100 most-cited scientists in Alzheimer's disease research and one of the top 25 scientists in free radical research. Perry is also the editor for numerous journals and is editor-in-chief for the Journal of Alzheimer's Disease. He is a fellow of the American Association for the Advancement of Sciences and past-president of the American Association of Neuropathologists.

Return to the Table of Contents


Scope and Content Note

The George Perry Papers include correspondence, email, grant files, committee files, drafts, laboratory notes, conference files, and slides that document his academic career and research activities primarily related to the cytopathology of Alzheimer's disease. The papers are organized into seven series: Correspondence, Grants, University Administration, Article drafts and correspondence, Professional Associations, Laboratory Notes, and Conferences.

Correspondence series includes 31 ft. of letters and 38, 839 emails written by or to Perry between 1976-2010 and is organized alphabetically by correspondent last name, journal title, or organization. Grants files include 5 ft. of planning material, proposals, and reports organized alphabetically by title. A majority of the grant files pertain to a 2004-2005 training grant in cellular and molecular aging. University Administration series consists of 2 ft. of committee minutes, agendas, reports related to committees Dr. Perry served on at Case Western Reserve School of Medicine and the University of Texas at San Antonio and are organized alphabetically by committee. Article drafts and correspondence series includes 7 ft. of drafts, correspondence, and referee reports of journal articles submitted for publication and is organized chronologically by year. Professional Associations and Conferences series include 3 ft. reference files and correspondence related to various Alzheimer and neuroscience organizations and conferernces.

This collection is housed at UTSA's HemisFair Park Campus.

Return to the Table of Contents


 

Organization of Collection

Due to size, this inventory has been divided into two finding aids which can be accessed by clicking on the following links:
I. Correspondence
II. Grants
III. University administration
IV. Article drafts and correspondence
V. Professional associations
VI. Laboratory notes
VII. Conferences

Return to the Table of Contents


Restrictions

Access Restrictions

Some items are restricted. Contact the UTSA university archives for details.

Usage Restrictions

The researcher assumes full responsibility for observing all copyright, property, and libel laws as they apply.

Return to the Table of Contents


Index Terms

Personal Names
Perry, George, 1953-.
Organizations
University of Texas at San Antonio.
Case Western Reserve University. School of Medicine.
Subjects
University of Texas at San Antonio. College of Sciences.
University of Texas at San Antonio--Faculty.
Alzheimer's disease--Research--History.
Alzheimer's disease--History--20th century.
Alzheimer's disease--Pathogenesis.
Alzheimer's disease--Pathophysiology.
Genres/Formats
Correspondence.
Memorandums.
Local Subjects
Education/Educators
UTSA History
Science and Technology

Return to the Table of Contents


Administrative Information

Preferred Citation

[Identification of item], George Perry Papers, UA 99.0020, University of Texas at San Antonio Libraries Special Collections.

Acquisition Information

Received as a gift from George Perry in July, 2012.

Return to the Table of Contents


Inventory of the George Perry Papers

 

Grants

Grant planning material, proposals, and reports organized alphabetically by title.
BoxFolder
49 22 Aging changes in neuronal function and structure, National Institutes of Health AG00795-10, 1987
21 Alterations of the calcium regulatory system and microtubules in muscular dystrophy cells, Muscular Distrophy Association post-doctoral fellowship, 1979-1980
18 American Health Assistance Foundation grant, 1986-1990
BoxFolder
31 3 American Health Assistance Foundation, 1990-2004
BoxFolder
49 17 Amyloid precursor in Alzheimer disease, National Institutes of Health AG00415, 1988-1993
Amyloid precursor in Alzheimer disease, National Institutes of Health AG07552
BoxFolder
49 23 1987-1990
19 Notice of award, 1988-1990
1 1993-1994
BoxFolder
50 2 1995-1996
BoxFolder
32 1 Anti-apoptotic activity of Alzheimer Aβ, National Insitutes of Health AG19356, 2000-2003
BoxFolder
49 20 Calcium control of microtubule polymerization, National Institutes of Health, 1980
15 Cataractogenesis: crystallin synthesis in Nakano mice, National Institutes of Health post-doctoral fellowship, 1978-1979
Cellular and molecular aging training program, National Institutes of Health T32-AG00105-11
BoxFolder
50 8 1994-2003
9 1994-2003
10 1994-2003
BoxFolder
49 11 1994-2003
BoxFolder
50 12 2004-2005
13 2004-2005
BoxFolder
51 1 2004-2005
2 2004-2005
3 2004-2005
4 2004-2005
5 2004-2005
6 2004-2005
7 2004-2005
8 2004-2005
9 2004-2005
10 2004-2005
BoxFolder
49 16 Cellular and molecular pathology of Alzheimer disease, National Institutes of Health AG08992, 1992-1993
BoxFolder
31 1 Control of neurofilament oxidative modification, National Institutes of Health R21 NS045353, 2002
BoxFolder
50 5 Cytoarchatectural alterations in Alzheimer disease, National Institutes of Health NS34349, 1994
BoxFolder
31 4 Ellision Medical Foundation, 1998-2004
5 Human Science Frontier Program, 1995-2002
BoxFolder
30 8 Immuno-modulation of neuronal AB and Tau, National Institutes of Health R01 AG20283, 2001
BoxFolder
31 7 Is oxidative damage a result of metabolic abnormalitiies in Alzheimer disease?, United Mitochondrial Disease Foundation, 1999-2004
BoxFolder
30 10 Mitochondrial dynamics in Alzheimer disease, National Institutes of Health R01 NS41789, 2001-2002
BoxFolder
31 6 Mizutani Foundation for Glycoscience, 1994-1997
7 Molecular Geriatrics, 1996
Molecular pathology of Alzheimer disease, National Institutes of Health RO1 AG08155
BoxFolder
50 6 1988
4 1992-1993
BoxFolder
31 National Institutes of Health Doctor's Pioneer Award, 2004
BoxFolder
51 11 National Institutes of Health objectives and opportunities in Alzheimer disease research, 1996
National Institutes of Health training grant
BoxFolder
32 3 1999
4 1999
5 1999
BoxFolder
50 3 Neurofibrillary pathology in Alzheimer disease, National Institutes of Health AG9287, 1989-1997
BoxFolder
31 1 Neurofilament proteins are specific targets of oxidative stress, Alzheimer's Association, 1998-2005
4 Non-invasive assessment of oxidative stress in patients with Alzheimer's disease, Philip Morris, 1995-1997
2 Olfactory neurons as a model F, Panacea Pharmaceuticals, 1999-2005
9 Oxidative protein modifications in amyotrophic lateral sclerosis, The Amyitrophic Lateral Sclerosis Association, 1995-2002
3 Oxidative stress and emmetropic lateral cirrhosis, Pepper Pilot Projects in Aging Research, 1996
6 Oxidative stress in Autism, Presidential Research Initiative Grant Program, 2005
5 Philip Morris Fellowship, 2003-2004
BoxFolder
50 7 Protein interaction in Alzheimer disease, American Health Assistance Foundation, 1990, 1993
BoxFolder
30 9 Redox active iron in Alheimer disease, National Institutes of Health DK57785, 1999
BoxFolder
32 2 Regulation of Aβ prooxidant activity, National Institutes of Health R01AG19374, 2000-2002
BoxFolder
31 8 RNA oxidation: a novel biomarker for Alzheimer's disease, National Institutes of Health NIH R01 AG09287, 1999-2006
2 Role of metals in oxidative balance in Alzheimer disease, Alzheimer's Association, 1999-2006
Training in cellular and molecular aging
BoxFolder
32 6 2004-2005
7 2004-2005
8 2004-2005
9 2004-2005
BoxFolder
33 1 2004-2005
BoxFolder
31 8 Yamshon Memorial Scholarship for Alzheimer Disease Research, 1996-2003
Box
35 Grant proposals [RESTRICTED], undated

Return to the Table of Contents




 

University administration

Committee minutes, agendas, reports related to committees Dr. Perry served on at Case Western Reserve School of Medicine and the University of Texas at San Antonio organized alphabetically by committee.
Case Western Reserve School of Medicine
BoxFolder
29 2 Assorted committees, 1990-2005
1 Bylaws Committee, 2003-2005
3 Case Western Reserve University 2005-2006
BoxFolder
48 36 Committee on Fringe Benefits, 1996-1998
BoxFolder
29 4 Committee on Qualifications and Standards for Appointments, Promotions, and Tenure, 2003-2004
5 Conflict of interest form, 2000-2005
6 Faculty activity summary form, 1995-2005
Faculty Council
BoxFolder
48 37 Annual activity summary, 1994
38 Annual report, 1995
39 Attendance, 1994-1997
40 Benefits, 1994-1995
41 Budget, 1994-1996
42 Bylaws, 1992-1994
43 Cell Biology Department/Center, 1995
44 Chair appointments, 1993-1996
45 Committee to Review Committees, 1994-1995
46 Concerns, 1987-1996
47 Dean/Vice Provost, 1995-1996
48 Executive Committee, 1994-1995
49 Faculty Equity and Development Committee, 1993-1996
BoxFolder
49 50 Faculty Senate, 1996
1 Graduate program, 1994-1995
2 Honor code, 1993-1995
3 LCME Steering Committee, 1984, 1995
4 Medical Research Council, 1989
5 Medical student graduates, 1995-1996
6 Minutes/agendas, 1994-1996
7 Nominations/elections, 1991-1995
8 Physical Medical Center, 1994
9 Promotions, 1994-1996
10 Psychobiology, 1995
11 Qualifications and standards for promotion, 1993
12 Scarpa affair, 1995
BoxFolder
29 7 Tenure, 1994-1995
8 Faculty of Medicine agendas/minutes, 1994-1996
9 Inquiry Committee for Scientific Misconduct, 1997
BoxFolder
30 1 Interdisciplinary Strategic Plan Committee, 2003-2004
Pathology
BoxFolder
30 2 Chair Search Committee, 2000-2004
3 Finance Committee, 1990-1994
4 Self-Study Committee, 1998
6 President's Advisory Committee, 1996-2002
5 Telephone logs, 2002-2005
7 Undergraduate students, 1997-2000
University of Texas at San Antonio
Boxfolder
4914Strategic Planning Committee, 2006-2007

Return to the Table of Contents




 

Article drafts and correspondence

Drafts, correspondence, and referee reports of journal articles submitted for publication organized chronologically by year.
BoxFolder
42 56 P4, "Antibodies to neurofibrillary tangles of Alzheimer's disease raised from human and animal neurofilament fractions,"Laboratory Investigation, 1983
BoxFolder
43 2 P10, Microtubules are not altered in the dystrophic chicken, Experimental Cell Research, 1985
3 P9, "Electron microscopic localization of Alzheimer neurofibrillary tangle componets recognized by an antiserum to paired helical filaments," Journal of Neuropathology and Experimental Neurology, 1985
9 P13, "Hirano bodies: a study of their composition," Journal of Neuropathology and Experimental Neurology, 1986
5 P17, " Immunocytochemical properties of Alzheimer straight filaments," Journal of Neuroscience, 1987
6 P16, "Antibodies to neuronal cytoskeleton are elicited by Alzheimer paired helical filament fractions," Brain Research, 1987
8 P14, "Ubiquitin is detected in neurofibrillary tangles and senil plaques neurites of Alzheimer brain," Proceedings of the National Academy of Sciences, 1987
27 P27, "Lewy bodies contain componets both shared and distinct from Alzheimer neurofibrillary tangles," 1987
11 P24, "The antigen recognized by the monoclonal antibody Alz 50 is associated with abnormal filaments in Alzheimer disease and progressive supranuclear palsy," Annuals of Neurology, 1988
16 P42, "Immunohistochemical recognition of ethylnitrosourea induced rat brain microrumors by anti-lue 7 monoclonal antibody," 1988
26 P34, "Immunochemical properties of ubiquitin conjugates inpaired filaments of Alzheimer disease," Journal of Neurochemistry, 1988
18 P43, 1989
22 P38, "The widespread alteration of neurites in Alzheimer disease may be unrelated to amyloid deposition," 1989
23 P39, "Tropomyosin isoform expression in normal and neoplastic astrocytes," 1989
15 P50, "Tropomyosin distinguishes Lewy bodies of Parkinson disease from other neurofibrillary pathology," Brain Research, 1990
20 P46, "The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease," American Journal of Pathology, 1990
21 P47, "Immunocytochemical localization of the erythroid transporter: abundance in tissues with barrier functions," Journal of Neuroscience, 1990
34 P53, "Widespread sreum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and related disorders," Journal of the British Neuropathology Society, 1990
70 "Neuritic plaques may originate from neurofibrillary tangles," Medical Hypotheses 40:257-258, 1993, 1990
BoxFolder
40 29 "Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease," Brain Research 558:312-314, 1991, 1991
BoxFolder
42 54 P55, "Basic fibroblast growth factor binding is a marker," Journal of Histochemistry and Cytochemistry, 1991
BoxFolder
44 27 "α-1-antitrypsin and α-1-antichymotrypsin are in the lesions of Alzheimer disease," Neuroreport 3:201-203, 1992, 1991
28 Brain Research 558:43-52, 1991, 1991
30 "Dementia with argyrophilic grains," Annuals of Neurology 30:853, 1991, 1991
32 American Journal of Tropical Medicine and Hygiene 46:391-397, 1992, 1991
BoxFolder
41 21 "Serum proteins and the blood-brain barrier in the pathogenesis of Alzheimer's disease," Advanced Biosciences 87:153-154, 1993, 1992
BoxFolder
44 29 "Aluminum accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure," Journal of Neurological Sciences 107:210-218, 1992, 1992
31 Bulletin of Clinical Neurosciences 56:107-119, 1991, 1992
BoxFolder
51 15 "Acetylcholinesterase and its association with the heparan sulphate proteoglycans in cortical amyloid plaques of Alzheimer's disease," Neuroscience 51:177-184, 1992, 1992
BoxFolder
40 16 "Abnormal accumulation of phopholipase C-delta in filament inclusions of neurodegenerative diseases," Neuroscience Letters 159:183-186, 1993, 1993
17 "Immunocytochemical evidence that the β-protein precursor is an integral component of neurofibrillary tangles of Alzheimer disease," American Journal of Pathology 143:1586-1593, 1993, 1993
18 "Serine protease inhibitor antithrombin III and is mRNA in the pathogenesis of Alzheimer's disease," American Journal of Pathology 143:886-983, 1993, 1993
25 "Amyloid P component and other acute phase proteins associated with cerebellar Aβ protein deposits in Alzheimer's disease," 1993
27 "The role of synaptic pathology in the mechanism of dementia in Alzheimer's disease," Clinical Neuroscience 1(4), 1994, 1993
35 "Chondrotin sulfate proteoglycans are associated with the lesions of Alzheimer's disease," Experimental Neurology 121:149-152, 1993, 1993
BoxFolder
41 18 "Rimmed vacuoles of inclusion body myositis and oculopharyngeal muscular dystrophy contain amyloid precursor protein and lysosomal markers," Brain Research 603:343-347, 1993, 1993
19 "Chondroitin sulfate proeoglycans are associated with the lesions of Alzheimer's disease," Experimental Neurology 121:149-152, 1993, 1993
20 "Alpha-trypsin immunoreactivity in Alzheimer disease," Biochemical and Biophysical Research Communications 193:579-584, 1993, 1993
BoxFolder
43 33 C25, "Transformation of neurofibrillary tangles in the extracellular space," 1993
BoxFolder
40 1 "Alteration of phospholipase C-δ protein level and specific activty in Alzheimer disease," Journal of Neurochemistry 1994, 1994
20 "Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer disease," American Journal of Pathology 145:42-47, 1994, 1994
21 "Advanced Maillard reaction end products are associated with Alzheimer disease pathology," Annuals of the New York Academy of Sciences 91:5710-5714, 1994, 1994
22 "Is a lewy body always a Lewy body?," Dementia in Parkinson's Disease, 1994 1994
26 "Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease," Biochemical and Biophysical Research Communications 209:657-663, 1995, 1994
31 "Chondrotin sulfate proteoglycans are a common component of neuronal inclusions and reacting astrocytes in neurodegeneratie diseases," Brain Research 656:205-209, 1994, 1994
BoxFolder
39 68 "Amyloidosis, advanced glycation end products and Alzheimer disease," Neuroreport 6:866-868, 1995, 1995
69 "Glycation in neuropathies," Trends in Neurosciences 18: 1, 1995, 1995
BoxFolder
40 4 "Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link," Diabetologia 39:247, 1996, 1995
5 "Evidence of oxidative stress in Pick disease and corticobasal degeneration," Brain Research 1995, 1995
6 "Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease," Journal of Neurochemistry 65:1995, 1995
7 "Alterations of low molecular weight acid phosphotase protein level in Alzheimer's disease," Brain Research 699:125-129, 1995, 1995
9 "Dystrophic neurites define diffues as well as core-containing senile plaques in Alzheimer's disease," Neurogeneration 4:235-237, 1995, 1995
11 "Early AGEing and Alzheimer's," Nature 374: 316, 1995, 1995
43 "APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology," Neurobiology of Alzheimer's Disease, 1995, 1995
3 "Glial cell extracellular matrix in Alzheimer's disease," Non-Neuronal Cells in Alzheimer's Disease, 1996, 1996
33 "Protein modifications and interactions in Alzheimer disease," Alzheimer's Disease: Aetological Mechanisms and Therapeutic Possibilities: Springer-Verlag, 1996, 1996
36 "Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease," Brain Research 737:195-200, 1996, 1996
38 "Is Alzheimer's a disease of oxidative stress?," Alzheimer Disease Review1:63-67, 1996, 1996
40 "Oxidative damage in Alzheimer's," Nature 382:120-121, 1996, 1996
41 "Early contribution of oxidative glycation in Alzheimer disease," Neuroscience Letters 217:210-211, 1996, 1996
44 "Artifactual strain-specific signs of incipient brain amyloidosis in APP transgenic mice," Neurobiology of Aging 17:223-234, 1996 1996
45 "A primary role for redox imbalance and oxidative damage in neurodegenerative diseases," 3rd World Congress on Biomedical Sciences at the Virtural Conference Hall, 1996
BoxFolder
42 36 "Alzheimer's disease, ageing, oxidative stress, and advanced glycation endproducts," Journal of Neural Transmission 105:439-461, 1998, 1997
43 "Neuronal oxidative stress is a common feature of Alzheimer and Parkinson diseases," Progress in Alzheimer's and Parkinson's Diseases 77-80, 1998, 1997
BoxFolder
39 1 "Mitochondrial abnormalities: a primary basis for oxidative damage in Alzheimer's disease," Drug Development Research 46:26-33, 1999, 1998
BoxFolder
42 22 "Striation is the dominant neuritic abnormality in Alzheimer disease," Brain Research 813:329-333, 1998, 1998
39 "Apoptosis and Alzheimer's disease," Science 282:1268-1269, 1998, 1998
41 "A suicide note from neurons in Alzheimer disease?," Nature Medicine 4: 897-898, 1998, 1998
46 "Altered glycosylation pattern of proteins in Alzheimer's disease," Journal of Neuropathology and Experimental Neurology 57:905-914, 1998, 1998
47 "Dyimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease," Free Radical Biology and Medicine 25:898-902, 1998, 1998
BoxFolder
39 3 "Role of oxidative stress in frontotemporal dementia," Dementia and Geriatric Cognitive Disorders 10: 85-87, 1999, 1999
38 "Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer Disease links oxidative stress to abnormal phosphorylation," Neuroreport 10:2411-2415, 1999, 1999
41 "Evidence of apoptosis in Cretzfeldt-Jakob Disease?," Journal of Neuropathology and Experimental Neurology, 1999 [unpublished], 1999
BoxFolder
41 1 "In situ oxidative catalysis by neuroibrillary tangles and senil plaques in Alzheimer disease: a central role for bound transition metals," Journal of Neurochemistry 74:270-279, 2000, 1999
BoxFolder
44 44 "Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease," Archives of Biochemistry and Biophysics 370:236-239, 1999, 1999
46 Science 285:663, 1999, 1999
49 RNA oxidation in Alzheimer and Parkinson diseases," Journal of Anti-Aging Medicine 2:227-230, 1999, 1999
50 "Serum amyloid P is not present in amyloid beta deposits of a transgenic animal model," NeuroReport 10:3229-3232, 1999, 1999
53 Review of Neurodegeneration Methods and Protocols, The Quarterly Review of Biology 74:510, 1999, 1999
BoxFolder
39 6 "Effect of the herbicide 4-CPA on human erythrocyte antioxidant enzymes in vitro," Redox Report 6:153-154, 2001, 2000
BoxFolder
41 7 "Oxidative stress, antioxidants and Alzheimer Disease," Alzheimer Disease and Associated Disorders International Journal 13:1327, 1987, 2000
BoxFolder
44 10 "Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation," Journal of Cell Biology 151:847-862, 2000, 2000
11 "Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of donryu rats on a cholesterol-enriched diet," The Anatomical Record 259:16-25, 2000, 2000
12 "Prospects for noninvasive imaging of brain amyloid β in Alzheimer's disease," Annuals of the New York Academy of Sciences 903:123-128, 2000, 2000
13 "Arson: tracking the culprit in Alzheimer's disease," Annuals of the New York Academy of Sciences 924:35-38, 2000, 2000
16 "Do neurons have a choice in death?," American Journal of Pathology 59:1011-1017, 2000, 2000
19 "Phophorylated, but no unmodified, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2nonenal," FEBS Letters 486:270-274, 2000, 2000
20 "Apoptotic cell death in Alzheimer disease: fiction?," Neurobiology of Aging 22:131-146, 2001, 2000
21 "Will antioxidants fulfill their expectations for the treatment of Alzheimer disease?," Mechanisms of Ageing and Development 116:169-179, 2000, 2000
22 "Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease," Journal of Neuropathology and Experimental Neurology 59:880-888, 2000, 2000
34 "Activation of NADPH oxidase in Alzheimer's disease brains," Biochemical and Biophysical Research Communications 273:5-9, 2000, 2000
35 "Sequestration of iron by Lewy bodies in Parkinson disease," Acta Neurologica, 2000
36 "Redox -active iron mediates amyloid-toxicity," Free Radical Biology and Medicine 30:447-450, 2001, 2000
39 "Alzheimer's disease : methods and protocols," Journal of Molecular Neuroscience 14:205, 2000, 2000
57 "The role of metals in neurodegenerative diseases," Cellular and Molecular Biology 46:731-741, 2000, 2000
59 "Evidence that the beta amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc," Journal of Biological Chemistry 275:19439-19442, 2000, 2000
BoxFolder
45 2 "Neuroinflammatory environments promote amyloid-β deposition and posttranslational modification," Neuroinflammation, 249-266, 2003, 2000
5 "Melatonin reduces interleukin secretion in amyloid-β stressed mouse brain slices," Chemico-Biological Interactions 134:101-107, 2001, 2000
BoxFolder
39 13 "Activation of MKK6, an upstream activator of p38, in Alzheimer's Disease," Journal of Neurochemistry 79:311-318, 2001, 2001
BoxFolder
41 37 "FTD and ADHD: pathology versus pathophysiology," Neurology, Psychiatry, and Brain Research 9:137-138, 2001, 2001
38 "Increase of CDK5 is related to neurofibrillary pathology in progressive supranuclear palsy," Neurology 58:589-292, 2002, 2001
39 "Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?," Neurochemistry International 40:527-531, 2002, 2001
BoxFolder
42 30 "Formation of aberrant phosphotau fibrillar polymers in neural cultured cells," European Journal of Biochemistry 269:1484-1489, 2002, 2001
BoxFolder
44 4 "Is oxidative damage specific?," Alzheimer Research Forum, 2002 2001
25 Peptides 23:1343-1350, 2002, 2001
BoxFolder
41 40 "Call for Elan to publish Alzheimer's trial details," Nature 416:677-678, 2002, 2002
46 "The six degrees of Medline," The Scientist 16:12, 2002, 2002
BoxFolder
42 10 "Dangers of the amyloid-β vaccination," Acta Neuropathologia 104:110, 2002, 2002
25 "Ill-fated amyloid-β vaccine," Journal of Neuroscience Research 69:285, 2002, 2002
28 "Causes and consequences of oxidative stress in Alzheimer's disease," Free Radical Biology and Medicine 32:1049, 2002, 2002
31 "The "Down's" side of mitchondria," Developmental Cell 2:255-256, 2002, 2002
BoxFolder
43 60 Proceedings of the 11th biennial meeting of the Society for Free Radical Research International, 2002
63 "Prion diseases and copper metabolism," 2002
64 "Differential regulation of glutamate receptors in Alzheimer disease," NeuroSignal 11:282-292, 2002, 2002
66 "Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice," Annuals of the New York Academy of Sciences 977:45-64, 2002, 2002
72 "Raman microscopy of isolated senile plaque cores reveals amyloid-beta arranged as beta-sheet metalloprotein," Biochemistry 42:2768-2773, 2003, 2002
73 "JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer disease," Journal of Neurochemistry 85:87-93, 2003, 2002
74 "Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies," NeuroReport 13:2035-2039, 2002, 2002
BoxFolder
44 8 "Effect of arachidonic acid and its oxidation products on tau phosphorylation," Journal of Neuroscience Research 71:863-870, 2003, 2002
51 "Harlequin and Alzheimer disease: remarkable parallels," Alzheimer Research Forum, 2002, 2002
52 "Specific responses to Aβ but not to the key questions," Alzheimer Research Forum, 2002, 2002
BoxFolder
45 7 "Therapeutic potential in Alzheimer disease," Current Medicinal Chemistry 9:1605-1610, 2002, 2002
9 "Metals and oxidative homeostasis in Alzheimer disease," Drug Development Research 56:293-299, 2002, 2002
10 "Amyloid-β and tau serve antioxidant functions in the aging and Alzheimer brain," Free Radical Biology and Medicine 33:1194-1199, 2002, 2002
14 "Amyloid-β: a vascular sealant that protects against hemorrhage," Journal of Neuroscience Research 70:356, 2002, 2002
16 "Elevated luteinizing hormone expression colocalizes with neurofibrillary tangles in Alzheimer disease," Journal of Neuroscience Research 70: 514-518, 2002, 2002
20 "Oxidative stress increases expression and activity of BACE in NT2 neurons," Neurobiology of Disease 10:279-288, 2002, 2002
BoxFolder
39 14 "Oxidative stress and neuronal adaptation in Alzheimer's Disease: the role of SAPK pathways," Antioxidants and Redox Signaling 5:571-576, 2003, 2003
15 Chapter, Alzheimer's Disease and Related Disorders: Research Advances 425-432, 2003 2003
19 "Amyloid-β induced toxicity of primary neurons is dependent upon differentiation associated increases in tau and cyclin-dependent kinase 5 expression," Journal of Neurochemistry 88:554-563, 2004, 2003
20 "Will preventing protein aggregates live up to its promise in neurodegenerative diseases?," Brain Pathology 13:630-638, 2003, 2003
26 "Distribution, levels, and activation of MEK1 in Alzheimer Disease," Journal of Neurochemistry 86:136-142, 2003, 2003
31 "X-ray contrast media induces aortic endothelial damage, which can be prevented with prior heparin treatment," Journal of Submicroscopic Cytology and Pathology 35:253-266, 2003, 2003
BoxFolder
41 55 "Mitogen-activated protein kinase pathways in nervous system and Alzheimer disease," Frontiers in Neurodegenerative Disorders and Aging 189-1999, 2004, 2003
56 "Neuronal cell cycle re-entry: a doomed journey in Alzheimer disease?," Frontiers in Neurodegenerative Disorders and Aging 200-206, 2004, 2003
BoxFolder
42 11 "Cerebral amyloid angiopathy: major contributor of decoratove response to Alzheimer disease pathogenesis," Neurobiology of Aging 25: 599-602, 2004, 2003
21 "Oxidative stress in Alzheimer disease: the earliest cytological and biochemical feature," Molecular Neurobiology of Alzheimer Disease and Related Disorders 164-171, 2004, 2003
52 "Homoxysteine and Alzheimer disease: a modifiable risk?," Free Radical Biology and Medicine 36:1471-1475, 2004, 2003
BoxFolder
43 57 "Tipping the apoptotic balance in Alzheimer disease: the abortosis concept," Cell Biochemistry and Biophysics 39:249-255, 2003, 2003
58 "The olfactory system in Alzheimer disease shows increased oxidative damage," Acta Neuropathologica 106:552-556, 2003, 2003
65 Letter to the editor, Science 299:1014, 2003, 2003
71 "Ectopic localization of phosphorylated histone3 in Alzheimer disease: a mitotic catastrophe," Act Neurologica 105:524-528, 2003, 2003
BoxFolder
39 52 "Concealment of epitope by reduction and alkylation in prion protein," Biochemical and Biophysical Research Communications 326:652-650, 2005, 2004
55 Proceedings of the XII biennial meeting of the Society for Free Radical Research Society, 2004, 2004
58 Biochimica et Biophysica Acta 1740:472-478, 2005, 2004
61 "Drug therapy in Alzheimer's Disease," New England Journal of Medicine 351:1911, 2004, 2004
62 "BACE-1 up-regulation induced by 4-hydroxynonenalis is mediated by stress activated protein kinases pathways," Journal of Neurochemistry 92:628-636, 2005, 2004
63 "Brain metabolic alterations are early signs in Alzheimer disease pathophysiology," Research and Practice in Alzheimer's Disease and Cognitive Decline Special Issue: 61-65, 2005, 2004
65 "Oxidative imbalance in Alzheimer disease," Molecular Biology 31:205-218, 2005, 2004
66 "Chronological primacy of oxidative stress in Alzheimer disease," Neurobiology of Aging 26:579-580, 2005, 2004
BoxFolder
41 24 "Soluble amyloid B-protein is increased in frontotemporal dementia with tau gene mutations," Journal of Alzheimer's Disease 6:45-51, 2004, 2004
29 "Abberant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease," Acta Neuropathologica 107:365-371, 2004, 2004
30 "Different perspectives on the amyloid-β cascade hypothesis," Journal of Alzheimer's Disease 6:137-145, 2004, 2004
31 "Therapeutic potential of oxidant mechanisms Alzheimer's disease," Expert Review of Neurotherapeutics 4:995-1004, 2004, 2004
43 "Mitotic and gender parallels in Alzheimer disease: therapeutic opportunities," Current Drug Targets 5:559-563, 2004, 2004
52 "Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-β precursor protein and amyloid-β deposition," Journal of Biological Chemistry 279:20539-20545, 2004, 2004
BoxFolder
42 5 "Amyloid-β and Alzheimer disease: a warning," The Scientist 8: 10, 26, 2004, 2004
7 "Mitochondrial failures in Alzheimer disease," American Journal of Alzheimer's Disease and Other Dementia 19:345-352, 2004, 2004
12 "Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease," Current Drug Targets 3:281-285, 2004, 2004
17 "Staying connected: synapes in Alzheimer disease," American Journal of Pathology 165:1461-1464, 2004, 2004
18 "Alzheimer's disease: a two hits wonder?," Alzheimer Research Forum, 2004, 2004
19 "Pathology is not necessarily pathogenic," Science of Aging Knowledge Environment Bulletin Board, 2004-10-29, 2004
51 "Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease," Neurological Research 25:665-674, 2003, 2004
BoxFolder
43 45 Mitogen-and strerss-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease," Journal of Neuroscience Research 79:554-560, 2005, 2004
48 "Neurotoxic-dopamine-quinone facilitates the assembly of tau into fibrillary ploymers," Molecular and Cellular Biochemistry 278:203-212, 2005, 2004
BoxFolder
39 23 "Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis," Annuals of the New York Academy of Sciences 1052:201-209, 2005, 2005
45 "Carosine: a versatile antioxidant and antiglycating agent," Science of Aging Knowledge Environment 18:pe12, 2005, 2005
53 "Amyloid-β in Alzheimer Disease: the horse or the cart? Pathogenic or protective?," Journal of Experimental Pathology 86:133-138, 2005, 2005
56 Chemical Research in Toxicology 18:1219-1231, 2005, 2005
BoxFolder
43 1 P2, "Characterization of a Ca2+-stimulated lipid oxidizing system in the sea urchin egg," "Fertilization stimulates lipid oxidation in the sea urchin egg," Developmental Biology, 1981-1984
4 P8, "Alzheimer's paired helical filaments contain cytoskeletal componets," Proceedings of the National Academy of Sciences, 1984-1985
7 P15, "Filaments of Pick's bodies contain altered cytoskeletal elements," American Journal of Pathology, 1986-1987
10 P25, "Amyloid precursor protein is in senile plaques of Alzheimer disease," The Lancet ii:746, 1988, 1987-1988
12 P23,"Arachidonic acid metabolism in ascidia ceratodes eggs: role g lipid peroxidation," Comparative Biochemistry and Physiology, 1987-1988
13 P22, "Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative disease," Proceedings of the National Academy of Sciences, 1987-1988
31 P21, "Influence of neuronal location on the antigenic properties of neurofibrillary tangles," Annuals of Neurology, 1987-1988
30 P20, "Paramyosin and actin in the schistosomal tegument: role in protective immunity," Nature, 1987-1989
29 P19, "Role of calmodulin in plasmodium falciparum: implications for erythrocyte invasion by the merozoite," European Journal of Cell Biology, 1987-1990
24 P30, "Immunoaffinity demonstration that paired helical filaments of Alzheimer disease sared epitopes with neurofilaments, MAP2 and tau," Brain Research, 1988-1989
28 P28, "(LI-8555) Ubiquitin is present on the cytokeratin intermediate filaments and mallory bodies of hepatocytes," Laboratory Investigation, 1988-1989
BoxFolder
42 53 P54, "Neuropil threads of Alzheimer disease show a marked alteration of the normal cytoskeleton," Journal of Neuroscience 463-488, 1991, 1988-1991
BoxFolder
43 54 "Filaments of lewy bodies contain insuluble cytoskeletal elements," American Journal of Pathology 140:809-822, 1992, 1988-1992
17 P44, "Glucose transporters are abundant in cells with "occluding" junctions at the bloody-eye barriers," Proceedings of the National Academy of Sciences, 1989-1990
19 P45, "Immunochemical demonstration of tropomysin in the neurofibrillary of Alzheimer disease," American Journal of Pathology, 1989-1990
14 P56, "Demonstration of a novel neurofilament associated antigen with neurofibrillary pathology of Alzheimer and related diseases," Brain Research, 1989-1991
BoxFolder
42 55 C23, "Alzheimer disease," Neuroscience Year, 1990-1991
BoxFolder
43 36 P51, "Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease," 1990-1991
53 "Association of heparan sulfate proteoglycan with the intraneuronal neurofibrillary pathology of Alzheimer disease," Journal of Neuroscience 11:3679-2683, 1991, 1990-1991
69 "Senile plaques neurites in Alzheimer disease accumulate amyloid precursor protein," Proceedings of the National Academy of Sciences 88:7552-7556, 1991, 1990-1991
52 "Neurofibrillary tangles contain β-amyloid precursor protein, β-protein and are associated with dystrophic neurites," Brain Research 560:303-305, 1991, 1990-1992
BoxFolder
44 26 "Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease," American Journal of Pathology 140:947-958, 1992, 1990-1992
BoxFolder
41 22 "The neuronal cytoskeleton," Neurology 42:1130, 1993, 1991-1992
BoxFolder
43 32 P68, "Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases," Brain Research, 1991-1992
39 P72, "Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal and aged Alzheimer disease brains," Acta Neuropathologica 85:233-240, 1992, 1991-1992
BoxFolder
44 17 "Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer disease," American Journal of Pathology 140:283-290, 1992, 1991-1992
BoxFolder
41 3 "Barrier properties of testis microvessels," Proceedings of the National Academy of Sciences 90, 1993, 1991-1993
5 "Quantitative solubilzation and analysis of SDS-insoluble paired helical filaments from Alzheimer disease," 1991-1996
BoxFolder
40 19 "Accumulation of the β amyloid precursor protein at sites of ischemic injury in rat brain," Journal of Neuroscience 13:3136-3142, 1993, 1992-1993
BoxFolder
41 4 "Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease," Brain Research 623:142-146, 1993, 1992-1993
BoxFolder
43 35 P71, "Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid precursor protein without cytoskeletal abnormalities," Brain Research, 1992-1993
37 P73, "Neuritic plaques in Alzheimer disease originate from neurofibrillary tangles," Medical Hypotheses, 1992-1993
38 P74, "Ontogeny of the erythroid/HepG2-type glucose transporter (GLUT-1) in the rat nervous system," Developmental Brain Research 72:41-49, 1993, 1992-1993
BoxFolder
39 73 "α1-trypsin interaction with the senile plaques of Alzheimer disease is mediated by β-protein precursor," Molecular and Chemical Neuropathology 27:145-154, 1996, 1993-1994
BoxFolder
40 2 "Advanced Maillard reaction end products are associated with Alzheimer disease pathology," Proceedings of the National Academy of Sciences 91:5710-5714, 1994, 1993-1994
12 "AJP 93-797 heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer disease," American Journal of Pathology 145:42-47, 1994, 1993-1994
30 "Alzheimer disease: an imbalance of proteolytic regulation?," Medical Hypotheses 42:277-279, 1994, 1993-1994
32 "Characterization of the association of phopholipase C-δ with Alzheimer neurofibrillary tangles," Brain Research 669:217-224, 1995, 1993-1994
BoxFolder
39 71 "Elastase is associated with the neurofibrillary pathology of Alzheimer disease: a putative link between proteolytic imbalance and oxidative stress," Restorative Neurology and Neurosciences 9:213-217, 1996, 1993-1996
BoxFolder
40 37 "Alzheimer disease: protein interaction and oxidative stress," Boletín de Estudios Médicos y Biologicos 44:5-10, 1996, 1993-1996
BoxFolder
39 70 "Ultrastructural localization of heme oxygenase-1 to the neurofibrillary pathology of Alzheimer disease," Molecular and Chemical Neuropathology 28:41-48, 1996, 1994-1995
72 "Free radical damage, iron, and Alzheimer's disease," Journal of Neurological Sciences 4769,1995, 1994-1995
BoxFolder
40 8 Neurology 45:1764-1765, 1995, 1994-1995
10 "Beta PP and tau interaction: a possible link between amyloid and tangle formation in Alzheimer's disease," American Journal of Pathology 148:79-87, 1996, 1994-1995
14 "Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer disease," Journal of Neurochemistry 64:2660-2666, 1995, 1994-1995
15 "Senile plaques and neurofibrillary tangles: the concurrent lesions of Alzheimer's disease," Neurobiology of Aging 16: 1995, 1994-1995
23 "Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease," Acta Neuropathologica 89:291-295, 1995, 1994-1995
24 "Tau binding to a conformation-dependent sequence of β-protein precursor in Alzheimer disease," 1994-1995
28 "The role of oxidative stress in Alzheimer disease," Trends in Neurosciences 18:172-176, 1995, 1994-1995
BoxFolder
41 2 "Plasma membrane abnormalities of dystrophic neutites in senile plaques of Alzheimer disease" and "Filament hetergeneity within the dystrophic neurites of senile plaques in Alzheimer disease," Acta Neuropathologica, 1994-1995
BoxFolder
40 13 Dawborn, D. and Allan, Neurobiology of Alzheimer's Disease , 1995-1996
34 "Oxidative stress and protein modification in neurodegenerative disease," Free Radicals in Brain Physiology and Disorders, 289-292, 1996, 1995-1996
39 "α-calcium-calmodulin-dependent kinase II is associated with paried helical filaments of Alzheimer's disease," Journal of Neuropathology and Experimental Neurology 55:954-963, 1996, 1995-1996
42 "Diseases of the aging brain: the role of oxidative stress," The Physician's Newsletter 1:3-4, 1996, 1995-1996
BoxFolder
42 40 "Oxidative damage: an early and central event in the pathogenesis of Alzheimer disease," Neurochemical Markers of Degenerative Disease and Drug Addiction, 93-110, 1998, 1996-1998
BoxFolder
39 4 "Alzheimer's Disease," Encyclopedia of Neuroscience, 1998 1996-1999
BoxFolder
42 42 "Oxidative damage in Alzheimer's disease," Neurogerontology and Neurogeriatrics 2:57-62, 1998, 1996-1999
16 "Advanced lipid peroxidation end-products in Alexander's disease," Brain Research 1998, 1997-1998
32 "Is oxidative damage central to the pathogenesis of Alzheimer disease?," Acta Neurologica Belgica 98:175-179, 1998, 1997-1998
33 "Cerebrovascular muscle atrophy is a feature of Alzheimer's disease," Brain Research 791:63-66, 1998, 1997-1998
34 "The case for vascular abnormalities in Alzheimer's disease," Current Research in Alzheimer's Disease 3:181-186, 1998, 1997-1998
35 "Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine," The Journal of Histochemistry and Cytochemistry 46:731-735, 1998, 1997-1998
38 "Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress," Journal of Neurochemistry 70:2212-2215, 1998, 1997-1998
44 "Primary involvement of oxidative damage and redox imbalance in Alzheimer and other neurodegenerative diseases," Redox Regulation of Cell Signaling and Its Clinical Application, 1998, 1997-1998
BoxFolder
44 40 "Alexander disease: Alzheimer disease of the developing brain?," Alzheimer Disease and Associated Disorders 13:232-235, 1999, 1997-2000
BoxFolder
45 1 "In Alzheimer disease, heme oxygenase is coincident with Alz50, an epitope of τ induced by 4-hydroxy-2nonenal modification," Journal of Neurochemistry 75:1234-1241, 2000, 1997-2000
BoxFolder
39 2 "Redox metals and neurodegenerative disease," Current Opinion in Chemical Biology 3: 220-225, 1999, 1998-1999
35 Biocongugate Chemistry 10:112-118, 1999, 1998-1999
36 "Quinone reductase NQO1, a sensative redox indicator, is selectively increased in Alzheimer disease," Redox Report 4:23-27, 1999, 1998-1999
37 Neuroscience 89:687-700, 1999, 1998-1999
39 Genetic evidence for oxidative stress in Alzheimer's Disease," Neuroreport 10:1355-1357, 1999, 1998-1999
40 "Es la lesion producida por oxidacion una parte central en la patogenesis de la enfermedad de Alzheimer?," Neurologia 1728.0 1999, 1998-1999
42 "Is increased redox-active iron in Alzheimer Disease a failure of the copper-binding protein ceruloplasmin?," Free Radical Biology and Medicine 26:1508-1512, 1999, 1998-1999
43 "Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA," American Journal of Pathology 154:1423-1429, 1999, 1998-1999
BoxFolder
42 37 "What are the facts and artifacts of the pathogenesis and etiology of Alzheimer disease," Journal of Chemical Neuroanatomy 16:35-41, 1998, 1998-1999
45 "RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease," Journal of Neuoscience 19:1959-1964, 1999, 1998-1999
BoxFolder
44 45 "Neuronal oxidative damage in Alzheimer disease may be brought about by a fundamental shift in redox balance and oxidative metabolism," Recent Research Developments in Neurochemistry 2:277-285, 1999, 1998-1999
47 "In situ methods for detection and localization of markers of oxidative stress: application in the study of neurodegenerative disorders," Methods in Enzymology 309:133-152, 1999, 1998-1999
BoxFolder
41 8 "Overexpression of heme oxygenase-1 in neuronal cells: possible interaction with tau," Journal of Biological Chemistry 275:5395-5399, 2000, 1998-2000
17 "Molecular and cellular aspects of oxidative damage in Alzheimer's disease," Free Radicals in Brain Pathophysiology, 2000, 1998-2000
BoxFolder
44 56 "Oxidative stress in Alzheimer disease," Biochimica et Biophysica Acta 1502:139-144, 2000, 1998-2000
58 "What oxidative stress tells us about therapuetic targets for Alzheimer's disease," Current Opinion in Central and Peripheral Nervous System Investigational Drugs 2:423-426, 2000, 1998-2000
BoxFolder
43 56 Diabetes 50:2792-2808, 2001, 1998-2001
BoxFolder
41 6 "Vascular pathology in Alzheimer's Disease," Neurobiology of Aging 21:357-361, 2000, 1999-2000
9 Lipoperooxidation is selectively involved in progressive supranuclear palsy," Journal of Neuropathology and Experimental Neurology 59:393-397, 2000, 1999-2000
10 "Morphological features of regeneration of rabbit aortic endothelium after cryoinduced vascular damage," Journal of Submicroscopic Cytology and Pathology 31:495-502, 1999, 1999-2000
11 "Amyloid-β junkies," The Lancet 355:757, 2000, 1999-2000
12 "Oxidative damge in Alzheimer's disease: the metabolic dimension," International Journal of Developmental Neuroscience 18:417-421, 2000, 1999-2000
13 "Promise and pitfalls of therapeutics to modify oxidant balance in chronic disease," IDrugs 3:371-372, 2000, 1999-2000
14 "Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome," Annuals of the New York Academy of Sciences 893:362-364, 1999, 1999-2000
15 "Histochemical and immunocytochemical approaches to the study of oxidative stress," Clinical Chemistry Laboratory Medicine 38:93-97, 2000, 1999-2000
16 "How important is oxidative damage? Lessons from Alzheimer's disease," Free Radical Biology and Medicine 28:831-834, 2000, 1999-2000
BoxFolder
44 3 "Neuronal oxidative stress precedes amyloid-β deposition in Down Syndrome," Journal of Neuropathology and Experimental Neurology 59, 2000, 1999-2000
14 "Metabolic metallic, and mitotic sources of oxidative stress in Alzheimer disease," Antioxidants and Redox Signaling 2:413-420, 2000, 1999-2000
15 "Protein disulfide isomerase in Alzheimer disease," Antioxidants and Redox Signaling 2:485-489, 2000, 1999-2000
48 "Antioxidant reversal of oxidative stress-induced memory deficits," Neuroreport 10:I, 1999, 1999-2000
BoxFolder
39 10 "Oxidative damage is an early event in Alzheimer Disease," Journal of Neuropathology and Experimental Neurology 60:759-767, 2001, 1999-2001
12 "Induction of NADPH cytochrome P450 reductase by the Alzheimer amyloid β-protein," Journal of Neurochemistry 78:121-128, 2001, 1999-2001
BoxFolder
44 2 "Amyloidosis in Alzheimer disease," Les Amyloses 513-518, 2000, 1999-2001
37 "Homeostatic control of oxidant balance in Alzheimer disease," Recent Research Developments in Neurochemistry 3:157-159, 2000, 1999-2001
42 Mitchondrial abnormalities in Alzheimer's disease," Journal of Neuroscience 21:3017-3023, 2001, 1999-2001
BoxFolder
42 24 "Increased expression of NOS and ET-1 immunoreactivity in human colorectal metastatic liver tumours is associated with selective depression of constitutive NOS immunoreactivity in vessel endothelium," Journal of Submicroscopic Cytology and Pathology 34:37-50, 2002, 1999-2002
8 "In situ localization of non-enzymatic peroxidase-like activity of tissue -bound transition metals,"Current Protocols in Toxicology, Vol. 2, 17.4.1-17.4.8, 2004, 1999-2004
BoxFolder
39 5 "Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease," NeuroReport 12:1277-1280, 2001, 2000-2001
8 "Differential activation of neuronal erk, jnk/sapk and p38 in Alzheimer's Disease: the two-hit hypothesis," Mechanisms of Aging and Development 123:39-46, 2001, 2000-2001
9 "The effect of agonists and antagonists on the morphology of non-transformed human smooth muscle cell in vitro," Journal of Submicroscopic Cytology and Pathology 33:141-149, 2001, 2000-2001
BoxFolder
41 49 "Apoptotic and oxidative indicators in Alzheimer's disease," Neuromethods 37:225-246, 2002, 2000-2001
BoxFolder
42 3 "The role of oxidative stress in the pathphysiology of cerebrovascular lesions in Alzheimer's disease," Brain Pathology 12:21-35, 2002, 2000-2001
BoxFolder
43 55 "Induction of atherosclerotic lesions is associated with increased immunoreactivities of NADPH-diaphorase, inducible nitric oxide synthases (NOS) and endothelin-1 (ET-1) in intimal cells of thoracic aorta in Watanabe rabbits," Experimental and Molecular Pathology 71:40-54, 2001, 2000-2001
68 "Factors controlling oxidative damage in Alzheimer's disease," Free Radicals in Chemistry, Biology, and Medicine 417-423, 2000, 2000-2001
BoxFolder
44 5 "Mechanisms by which metals promote events connected to neurodegenerative diseases," Brain Research Bulletin 55:125-132, 2001, 2000-2001
6 "Oxidative imbalance is a major feature of Alzheimer disease," Current Topics in Biochemical Research 3:151-156, 2000, 2000-2001
18 "Erythrocyte, plasma and serum antioxidant activities in untreated toxic mulitnodular goiter patients," Free Radical Biology and Medicine 30:665-667, 2001, 2000-2001
23 "Activation and redistribution of JNK/SAPK in Degenerating Neurons in Alzheimer disease," Journal of Neurochemistry 76:435-441, 2001, 2000-2001
24 "Nitrotyrosine: a protective response?," Science 291:595-596, 2001, 2000-2001
33 "Abortive apoptosis in Alzheimer disease," Acta Neurologica 101:305-310, 2001, 2000-2001
38 "Research evaluation," The Scientist 15: 1, 2001, 2000-2001
41 "Active glycation in neurofibrillary pathology of Alzheimer disease: Ne-(carboxymethyl) lysine and hexitol-lysine," Free Radical Biology and Medicine 31:175-180, 2001, 2000-2001
BoxFolder
45 3 "Hibernation, a model of neuroprotection in traumatic brain injury," American Journal of Pathology 158:2145-2151, 2001, 2000-2001
4 "Oxidative damage and antioxidant responses in Alzheimer disease," Alzheimer Disease: Advances in Etiology, Pathogenesis and Therapeutics, 2001 2000-2001
BoxFolder
39 11 "High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal," Journal of Biological Chemistry 277:4644-4648, 2002, 2000-2002
BoxFolder
42 2 "The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications," CNS Drugs 16:339-352, 2002, 2000-2002
27 "Melatonin exhibits antioxidant properties in a mouse brain slice model of excitotoxicity," International Journal of Circumpolar Health 61:32-40, 2002, 2000-2002
BoxFolder
43 67 "Neurodegenerative disease: role of free radical damage," Research and Practice in Alzheimer's Disease 6:287-290, 2002, 2000-2002
BoxFolder
44 7 "Microtubule reduction in Alzheimer disease is independent of PHF formation," American Journal of Pathology 162:1623-1627, 2003, 2000-2002
BoxFolder
45 11 "Is oxidative damage the fundamental pathogenic mechanism of Alzheimer and other neurodegenerative diseases?," Free Radical Biology and Medicine 33:1475-1479, 2002, 2000-2002
17 "Labeling of cerebral amyloid-β deposits in vivo using intranasal bFGF and SAP component," Journal of Nuclear Medicine 43:1044-1061, 2002, 2000-2002
BoxFolder
41 23 Exercise and Disease, 7-16, 2003, 2000-2003
27 "Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease," Journal of Neuroscience Research 75:698-703, 2004, 2000-2004
51 "Neuroprotective properties of Bcl-w in Alzheimer's disease," Journal of Neurochemistry 279:20539-20545, 2004, 2000-2004
BoxFolder
39 67 "Oxidative damage and Alzheimer Disease: are antioxidant therapies useful?," Drug News and Perspectives 18:13-19, 2005, 2000-2005
7 "Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem lewy bodies," Neuroscience Letters 319: 28-35, 2002, 2001-2002
BoxFolder
41 35 "Involvement of Maillard reactions in Alzheimer's disease," Neurotox 4:191-209, 2002, 2001-2002
36 "Is Alzheimer's disease a mitochondrial disorder," The Neuroscientist 8:489-496, 2002, 2001-2002
41 "Systematic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy," Neurobiology of Disease 9:244-248, 2002, 2001-2002
42 "Oxidative damage to nucleic acids in human prion disease," Neurobiology of Disease 9:275-281, 2002, 2001-2002
47 "Oxidant and antioxidant responses in Alzheimer disease," Recent Research Developments in Biophysics and Biochemistry 1:35-41, 2001, 2001-2002
48 "The mitochondrial common deletion in Parkinson's disease and related movement disorders," Parkinsonism and Related Disorders 8:165-170, 2002, 2001-2002
BoxFolder
42 9 "Will anti-inflammatories fulfill their promise?," Alzheimer's Research Forum, 2001-2002, 2001-2002
23 "Predicting the failure of amyloid-β vaccine," The Lancet 359:1864-1865, 2002, 2001-2002
26 "Reactive oxygen: its sources and significance in Alzheimer disease," Journal of Neural Transmission 62:67-73, 2002, 2001-2002
29 "Microglial activation and amyloid-β clearance induced by exogenous heat-shock proteins," The FASEB Journal 10.1096/fj.01-0530fje, 2002-02-25, 2001-2002
BoxFolder
43 61 "Amyloid-β: a (life) preserver for the brain," Neurobiology of Aging 23:1097-1099, 2002, 2001-2002
BoxFolder
44 43 "The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease?," Peptides 23:1333-1341, 2002, 2001-2002
54 "Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease," Biometals 16:77-81, 2003, 2001-2002
55 "Comparative biology and pathology of oxidative stress in Alzheimer and other neurodegenerative diseases: beyond damage and response," Comparative Biochemistry and Physiology 133:507-513, 2002, 2001-2002
BoxFolder
45 6 "Role of the antioxidant ascorbate in hibernation and warming from hibernation," Comparative Biochemistry and Physiology 133:483-492, 2002, 2001-2002
8 "Iron: a pathological mediator of Alzheimer's disease?," Developmental Neuroscience 24:184-187, 2002, 2001-2002
12 "Role of heme catabolism in neurodegenerative diseases," Physiology/Pathology of Heme Oxygenase, 135-143, 2002, 2001-2002
13 "Alzheimer disease and oxidative stress," Journal of Biomedicine and Biotechnology 2:120-123, 2002, 2001-2002
15 "Role of mitchondrial dysfunction in Alzheimer's disease," Journal of Neuroscience Research 70:357-360, 2002, 2001-2002
18 "Neuronal survival and death in Alzheimer disease," Mapping the Progress of Alzheimer's and Parkinson's Disease, 49-57, 2002, 2001-2002
19 "The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress and tau," Neurobiology of Aging 23:855-859, 2002, 2001-2002
BoxFolder
39 17 "The role of oxidative mechanisms in neurodegenerative diseases," Neurodegeneration 8-10, 2003 2001-2003
21 "Metal homeostatsis relates to oxidative stress in Alzheimer's Disease," Redox Genome Interactions in Health and Disease 425-437, 2004, 2001-2003
22 "Role of vascular hypoperfusion induced oxidative stress and mitocondria failure in the pathogenesis of Alzheimer Disease," Neurotoxicity Research 5:385-390, 2003, 2001-2003
29 "Copper mediates dityrsine crosslinking of Alzheimer's amyloid-β," Biochemistry 43:560-568, 2004, 2001-2003
BoxFolder
43 40 "Microtubule reduction in Alzheimer disease is independent of PHF formation," American Journal of Pathology 162:1623-1627, 2003, 2001-2003
BoxFolder
44 9 "Role of high mobility group protein-1 (HMG-1) in senile plaque homeostasis in Alzheimer's disease," Biochemical and Biophysical Research Communications 301:699-703, 2003, 2001-2003
BoxFolder
39 16 "Metal-catalyzed redox activity in neurodegenerative diseases," Metal Ions and Neurodegenerative Disorders 1-14, 2003, 2002-2003
18 "Amyloids, aggregates and neuronal inclusions," Current Medicinal Chemistry 3:293-298, 2003, 2002-2003
25 "Hydroxynonenal , toxic carbonyls, and Alzheimer Disease," Molecular Aspects of Medicine 24:305-313, 2003, 2002-2003
27 "Increased p27, an essential component of cell cycle control, Alzheimer's Disease," Aging Cell 2:105-110, 2003, 2002-2003
28 "Oxidative stress and predominant Aβ 42(43) deposition in myopathies with rimmed vacuoles, Acta Neuropathologica 105:581-585, 2003, 2002-2003
30 "A metabolic basis for Alzheimer Disease," Neurochemistry Research 28:1549-1552, 2003, 2002-2003
32 Redox Report 8:129-133, 2003, 2002-2003
33 "4-Hydroxynonenal contributes to NGF withdrawal induced neuronal apoptosis," Journal of Neurochemistry 85:999-1005, 2003, 2002-2003
34 "Functional implications of antiestrogen induction of quinone reductase: inhibition of estogen-induced DNA damage," Molecular Endocrinology 17:1344-1355, 2003, 2002-2003
44 "Amyloid-β the good, the bad, and the ugly," Brain Research Review 43:1-16, 2003, 2002-2003
BoxFolder
42 4 "Hypoperfusion, mitochondria failure, oxidative stress, and Alzheimer disease," Journal of Biomedicine and Biotechnology 2003:162-163, 2003, 2002-2003
BoxFolder
43 59 "Apoptotic promoters and inhibitors in Alzheimer disease: who wins out?," Progress in Neuropsychopharmacology and Biological Psychiatry 27:251-254, 2003, 2002-2003
62 "The role of MAPK pathways in Alzheimer disease," NeuroSignals 11:270-281, 2002, 2002-2003
75 "Sources contributing to the initiation and propagation of oxidative stress in Alzheimer disease," Proceedings of the Indian National Academy of Sciences 69:251-260, 2003, 2002-2003
BoxFolder
44 1 "Vascular hypoperfusion, mitochondria failure and oxidative stress in Alzheimer disease," Proceedings of the Indian National Academy of Sciences 69:209-238, 2003, 2002-2003
BoxFolder
39 24 "La función del estrés oxidativo en la patogénesis de la enfermedad de Alzheimer/The role of oxidative stress in the pathogenesis of Alzheimer's Disease," Revista Chilena de Neuro-Psiquiatria 41:47-52, 2003, 2002-2004
BoxFolder
41 25 "Increased neuronal RNA oxidation in familial Alzheimer disease," Neurobiology of Disease 17:108-113, 2004, 2002-2004
BoxFolder
42 1 "The role of leutinzing hormone in the pathogenesis of Alzheimer disease," Principles of Gender Specific Medicine, 1234-1237, 2004, 2002-2004
48 "When hypotheses dominate: established ideas can strangle the assessment of valid alternatives," The Scientist 18: 6, 2004, 2002-2004
49 "Neurofilament proteins in neurodegenerative diseases," Cellular and Molecular Life Sciences 61:3057-3075, 2004, 2002-2004
BoxFolder
43 44 "Is tau a potential therapeutic target in neurodegenerative disorders?," Trends in Molecular Medicine 11: 164-169, 2005, 2002-2004
BoxFolder
39 46 "Pathobiology of familial hypercholesterolemic atherosclerosis," International Journal of Experimental Pathology 36:225-240, 2004, 2003-2004
57 "Oxidative stress mechanisms and potential therapeutics in Alzheimer Disease," Journal of Neural Transmission 112:921-932, 2005 2003-2004
64 "Mitochondrial DNA deletions in atherosclerolic hypoperfused brain microvessels as a primary target for the development of Alzheimer's Disease," Journal of Neurological Science 229:285-292, 2005, 2003-2004
BoxFolder
41 26 "Challenging the amyloid cascade hypothesis: senile plaques and amyloid-β as protective adaptations to Alzheimer disease," Annuals of the New York Academy of Sciences 1019:1-4, 2004, 2003-2004
28 "Oxidative stress and redox-active iron in Alzheimer's disease," Annuals of the New York Academy of Sciences 1012:179-182, 2004, 2003-2004
32 Oxidative stress mechanisms and potential therapeutic modalities in Alzheimer disease," Medicinal Chemistry Reviews 1:19-23, 2004, 2003-2004
33 "Alzheimer's disease: the two-hit hypothesis," The Lancet Neurology 3:219-226, 2004, 2003-2004
34 "Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients," Aging Cell 3:41-44, 2004, 2003-2004
44 "Accelerated α-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells," Brain Research 1013:51-59, 2004, 2003-2004
50 "Regulation of glycogen synthase kinase-3 [beta] by products of lipid perioxidation in neuroblastoma cells," Journal of Neurochemistry 89:1224-1232, 2004, 2003-2004
53 "Alzheimer's disease," Encyclopedia of Neuroscience, 2004, 2003-2004
54 "Heme catabolism and heme oxygenase in neurodegeneration disease," Antioxidants and Redox Signaling 6:888-894, 2004, 2003-2004
57 "Eat less, eat better, and live longer: does it work and is it worth it? The role of diet in aging and disease," The Fountain of Youth: Cultural, Scientific, and Ethical Perspectives on a Biomedical Goal, 201-227, 2004, 2003-2004
BoxFolder
42 13 "The role of redox active iron in Alzheimer disease," Current Medical Literature-Neurology 20:25-30, 2004, 2003-2004
14 "The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease," In Vivo 18:325-334, 2004, 2003-2004
15 "Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species," Journal of Alzheimer's Disease 6:165-169, 2004, 2003-2004
50 "Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease," Ageing Research Reviews 3:319-326, 2004, 2003-2004
BoxFolder
43 41 "Tau modifiers as therapeutic targets for Alzheimer's disease," Biochimica et Biophysica 1739:211-215, 2005, 2003-2004
51 "Alzheimer-specific epitopes of tau represent lipid perioxidation induced conformations," Free Radical Biology and Medicine 38:746-754, 2005, 2003-2004
BoxFolder
39 50 Retinoic acid isomers protect hippocampal neurons from amyloid-β induced neurodegeneration," Neurotoxicity Research 7:243-250, 2005, 2003-2005
54 "Gender differences in Alzheimer Disease: the role of luteinizing hormone in pathogenesis," Alzheimer's Disease and Associated Disorders 19:95-99, 2005, 2003-2005
BoxFolder
41 45 "Oxidative stress signaling in Alzheimer disease," Brain Research 1000:32-39, 2004, 2003-2005
BoxFolder
43 46 "Evidence for the role of gonadotropin hormones in the development of Alzheimer disease," Cellular and Molecular Life Sciences 62:293-298, 2005, 2003-2005
BoxFolder
39 47 "Ferric cycle activity and Alzheimer Disease," Current Neurovascular Research 2:261-267, 2005, 2004-2005
48 "Involvement of complex carbohydrate chemistry in Alzheimer's disease," Medical Hypotheses and Research 2:393-400, 2005, 2004-2005
49 "Mitochondria and Alzheimer's Disease: A powerful link," Mitochondrial News 9:1, 8, 15, 2004, 2004-2005
51 "Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron," Journal of Biological Chemistry 280:20978-20986, 2005, 2004-2005
59 "The MAPKs are differentially mediated in artic ground squirrels during hibernation," Journal of Neuroscience Research 80:862-868, 2005, 2004-2005
60 "Oxidative stress neurodegeneration," Annuals of the New York Academy of Sciences 1043:1-8, 2005, 2004-2005
BoxFolder
42 6 "Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease," Journal of Mitochondrion 4: 649-663, 2004, 2004-2005
20 "Alzheimer disease: oxidative stress and homeostatic regulation," Revista de Faculdade de Medicina de Lisboa 9:455-460, 2004, 2004-2005
BoxFolder
43 42 "Therapeutic opportunities in Alzheimer disease," Current Medicinal Chemistry 12:1137-1147, 2005, 2004-2005
43 "A second look into the oxidant mechanisms in Alzheimer's disease," Current Neurovascular Research 2:179-184, 2005, 2004-2005
47 "Chitin in Alzheimer disease brains," Current Alzheimer Research 2:419-423, 2005, 2004-2005
49 "Oxidative stress: the old enemy in Alzheimer's disease pathophysiology," Current Alzheimer Research 2:403-408, 2005, 2004-2005
50 "Alzheimer's disease and oxidative stress: the old program remains unsolved," Current Medicinal Chemistry 5:51-62, 2005, 2004-2005
25 P33, undated
Box
36-37 Referee reports [RESTRICTED], undated

Return to the Table of Contents




 

Professional associations

Correspondence and subject files related to professional associations organized alphabetically by title.
BoxFolder
34 1 American Association for the Advancement of Science, 1997-2006
2 American Association of Neuropathologists, 1985-2003
3 American Institute of Biological Sciences, 1999
4 American Men and Women of Science, 1988-2002
5 American Society of Cell Biology, 1992-2005
6 American Society for Investigative Pathology, 1987-2005
7 American Society for Neurochemistry, 1996-2001
8 American Association of Pathology Chairs, 2001-2004
9 Cleveland Society of Pathologists, 1988-1997
10 Federation of American Societies for Experimental Biology (FASEB), 1996-2000
11 First International Congree on Alzheimer's Disease, 1987-1988
12 Histology Society of Ohio, 1993
13 International College of Geriatric Psychoneuropharmacology, 2001-2003
14 International Mailard Reaction Society (IMARS), 2005
15 Microscopic Society of America, 1991-1996
16 Microscopy Society of Northeastern Ohio, 1995-2004
17 Mitocondrion Research Society, 1999
18 Mytosis Association, 2005
19 Sigma Xi, 1997-2006
20 Society for Neuroscience, 1996-2004
21 Society of Neuroscientists in Africa (SONA), 1994-1997
22 United States and Canada Academy of Pathologists, 2000-2005
23 Universities Associated for Research and Education in Pathology, 2002
24 University Pathologists of Cleveland, 1986-1993

Return to the Table of Contents




 
BoxFolder
5116Laboratory notes 1982-1988

Return to the Table of Contents




 

Conferences

Correspondence and conference proceedings related to professional conferences organized alphabetically by title.
BoxFolder
38 15 2nd European Ipsen Symposium, 2005
6 35th Annual Meeting of the American Society for Neurochemistry, 2004
16 4th International Congress on Vascular Dementia, 2005
12 7th International Conference on Alzheimer's and Parkinson's Diseases, 2005
7 8th International Symposium on the Malliard Reaction, 2004
BoxFolder
33 12 Alzheimer's Disease: The Therapeutic Era, 1998
18 American College of Neuropsychopharmacology, 1999
BoxFolder
38 1 Case Western Reserve School of Medicine Education Retreat, 2004
4 Challenging Views of Alzheimer's Disease, 2004
14 Experimental Biology, 2005
BoxFolder
33 3 Fifth International Conference on Alzheimer's Disease and Related Disorders, 1996
11 Fourth Hungarian Conference on Alzheimer's Disease, 1998
2 Fourth International Congress of Movement Disorders, 1996
19 Fourth International Symposium on Medical Chemistry of Neurodegenerative Diseases, 2000
8 Gordon Conference, Intermediate Filaments 1998, 1995-2002
6 Gordon Conference, Oxygen Radicals in Biology, 1998
Gordon Conference. Oxidative Stress and Disease
BoxFolder
33 14 1999
23 2001
BoxFolder
38 11 International Conference on Inclusion-Body Myositis, 2005
BoxFolder
33 22 International Society for Free Radical Research, 2000
BoxFolder
38 13 International Symposium on Aging and Neurodegeneration, 2005
17 International Symposium on the Biology of Brain and Mind Disorders, 2005
9 KCIST, 2004
BoxFolder
33 7 Manhattan Alzheimer's Disease Conference, 1998
4 Microscopy and Microanalysis, 1997
10 Molecular and Genomic Effects of Tissue Oxygen Deprivation in Sleep Apnea, 1998
21 Neuromuscular Disorders and Aging, 2000
15 Neuronal Apoptosis, 1999
BoxFolder
38 8 New Approaches in Alzheimer's Disease Therapy, 2004
BoxFolder
33 17 NIA Imaging and Biological Markers for Diagnosis of Alzheimer's Disease, 1999
BoxFolder
38 5 Ninth International Conference on Alzheimer's Disease and Related Disorders, 2004
Oxygen Club of California
BoxFolder
33 5 1998
13 1999
BoxFolder
38 3 Portuguese Dementia Group, 2004
BoxFolder
33 9 Sixth International Conference on Alzheimer's Disease and Related Disorders, 1998
16 Sixth Meeting of the Portuguese Society of Neuroscience, 1999
BoxFolder
38 10 Third International Workshop on Iron and Copper Homeostatis, 2004
2 Twelfth Biennial Meeting of the Society for Free Radical Research International, 2004
BoxFolder
33 20 World Alzheimer Congress, 2000

Return to the Table of Contents




 

Return to Part 1 of the George Perry papers

Return to the Table of Contents




Page | 1 | 2 |